Related Experiment Video
Updated: Aug 5, 2025

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Case Series of End-Stage Liver Disease Patients with Severe Coccidioidomycosis
Daniel Ho1, Kristen D Kelley1, Satya Dandekar2
1Department of Internal Medicine, University of California Davis, Sacramento, CA 95817, USA.
Abstract:
Liver disease causes relative compromise of the host immune system through multiple overlapping mechanisms and is an established risk factor for invasive fungal diseases including candidiasis and cryptococcosis. This immunologic derangement also leads to rapid progression of disease with resultant increases in morbidity and mortality. We describe severe coccidioidomycosis cases in the setting of liver dysfunction. Collaborative multi-center epidemiologic studies should be performed to determine the incidence of severe coccidioidomycosis in patients with concurrent liver disease.
Insights
Liver disease weakens the immune system, increasing risks for fungal infections like coccidioidomycosis. This study highlights severe coccidioidomycosis cases in patients with liver dysfunction, emphasizing the need for further research.
Area of Science:
- Immunology
- Infectious Diseases
- Hepatology
Background:
- Liver disease compromises host immunity via multiple mechanisms.
- It is a known risk factor for invasive fungal infections (e.g., candidiasis, cryptococcosis).
- Immunologic compromise from liver dysfunction accelerates disease progression, increasing morbidity and mortality.
Purpose of the Study:
- To describe cases of severe coccidioidomycosis in patients with liver dysfunction.
- To highlight the potential link between liver disease and severe coccidioidomycosis outcomes.
- To underscore the need for further investigation into this association.
Main Methods:
- Case series description of severe coccidioidomycosis.
- Analysis of patient data in the context of concurrent liver dysfunction.
- Review of clinical presentations and outcomes.
Main Results:
- Severe coccidioidomycosis was observed in patients with underlying liver dysfunction.
- The presence of liver disease may exacerbate coccidioidomycosis severity.
- This association warrants further epidemiological investigation.
Conclusions:
- Liver dysfunction is associated with severe coccidioidomycosis.
- Collaborative multi-center studies are needed to determine the incidence of severe coccidioidomycosis in patients with liver disease.
- Understanding this relationship is crucial for patient management and public health strategies.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Fungal Phylum Microsporidia
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

